TY - JOUR
T1 - Consensus recommendations for 4th generation non-microneedling monopolar radiofrequency for skin tightening
T2 - A delphi consensus panel
AU - Chapas, Anne
AU - Biesman, Brian S.
AU - Chan, Henry Hin Lee
AU - Kaminer, Michael S.
AU - Kilmer, Suzanne L.
AU - Lupo, Mary P.
AU - Marmur, Ellen
AU - Dyke, Susan Van
N1 - Funding Information:
The authors would like to thank Jeffrey S. Dover MD, FRCPC, (SkinCare Physicians, Chestnut Hill, MA) for his expert review of the manuscript, and Judi Miller (SRxA, McLean, VA) for assistance with consensus statement methodology research, questionnaire design and interpretation, and manuscript preparation. Ms. Miller's work was financially supported by Solta Medical.
Publisher Copyright:
Copyright © 2020
PY - 2020/1
Y1 - 2020/1
N2 - Importance: The demand for non-invasive methods for facial and body rejuvenation has experienced exponential growth over the last two decades. While multiple treatment systems exist, device specific guidelines to help guide clinicians to achieve the best outcomes are lacking. Objective: To develop expert consensus on the use of 4th generation non-microneedling monopolar radiofrequency. Design: In a modified Delphi process, a panel of 8 international experts in aesthetic dermatology participated in 3 rounds of consensus building commencing in April 2019. Initially, 32 consensus statements were developed addressing patient selection, patient outcomes, treatment settings, and practical use of non-microneedling monopolar radiofrequency. By the 3rd round, these had been reduced and refined to a total of 19 statements. The consensus process was completed in June 2019 and the data were analyzed in July 2019. Results: In 3 Delphi rounds, the 8 panelists achieved consensus on 19 recommendations on the use of 4th generation non-microneedling monopolar radiofrequency and developed additional explanatory guidance to support 12 of the consensus statements including those related to patient selection, procedural technique, and anticipated treatment outcomes. Conclusions and Relevance: Although guidelines will never replace individual clinical judgment, as the demand for noninvasive tissue tightening increases, so too does the need for positive, reproducible outcomes. Careful patient selection, pre-treatment counseling, treatment planning, and good technique, are all critical for success. These consensus statements should assist clinicians in each of these areas.
AB - Importance: The demand for non-invasive methods for facial and body rejuvenation has experienced exponential growth over the last two decades. While multiple treatment systems exist, device specific guidelines to help guide clinicians to achieve the best outcomes are lacking. Objective: To develop expert consensus on the use of 4th generation non-microneedling monopolar radiofrequency. Design: In a modified Delphi process, a panel of 8 international experts in aesthetic dermatology participated in 3 rounds of consensus building commencing in April 2019. Initially, 32 consensus statements were developed addressing patient selection, patient outcomes, treatment settings, and practical use of non-microneedling monopolar radiofrequency. By the 3rd round, these had been reduced and refined to a total of 19 statements. The consensus process was completed in June 2019 and the data were analyzed in July 2019. Results: In 3 Delphi rounds, the 8 panelists achieved consensus on 19 recommendations on the use of 4th generation non-microneedling monopolar radiofrequency and developed additional explanatory guidance to support 12 of the consensus statements including those related to patient selection, procedural technique, and anticipated treatment outcomes. Conclusions and Relevance: Although guidelines will never replace individual clinical judgment, as the demand for noninvasive tissue tightening increases, so too does the need for positive, reproducible outcomes. Careful patient selection, pre-treatment counseling, treatment planning, and good technique, are all critical for success. These consensus statements should assist clinicians in each of these areas.
UR - http://www.scopus.com/inward/record.url?scp=85078573495&partnerID=8YFLogxK
U2 - 10.36849/JDD.2020.4807
DO - 10.36849/JDD.2020.4807
M3 - Article
C2 - 31985194
AN - SCOPUS:85078573495
SN - 1545-9616
VL - 19
SP - 20
EP - 26
JO - Journal of Drugs in Dermatology
JF - Journal of Drugs in Dermatology
IS - 1
ER -